Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
MP

Michael Paal — 16 Patents

Eli Lilly: 10 patents #344 of 2,858Top 15%
BEBehringwerke: 3 patents #63 of 317Top 20%
MPMillennium Pharmaceuticals: 2 patents #358 of 771Top 50%
CTCor Therapeutics: 1 patents #28 of 54Top 55%
Hamburg, DE: #187 of 5,803 inventorsTop 4%
Overall (All Time): #284,196 of 4,157,543Top 7%
16 Patents All Time
Michael Paal has been granted 16 US patents while listed as an inventor at Eli Lilly. The first was granted in 1990 and the most recent in March 2005. Michael Paal ranks #284,196 of 4,157,543 US inventors in our database (top 6.8%). Patent records list Michael Paal in Hamburg, DE.

Patents per Year

Patents granted per year, 1990 to 2005Bar chart with a peak of 3 patents in 1990.peak 31990: 3 patents19901996: 2 patents19961997: 3 patents19971998: 1 patents19982000: 1 patents20002001: 1 patents20012002: 2 patents20022003: 1 patents20032004: 1 patents20042005: 1 patents2005

Issued Patents All Time

Showing 1–16 of 16 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
6867198 Agents and methods for the treatment of proliferative diseases Rima Al-Awar, Kyle Andrew Hecker, James E. Ray, Jianping Huang, Sajan Joseph +6 more 2005-03-15 $269,325,000
6693109 Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation Matthew Joseph Fisher, Joseph A. Jakubowski, John Joseph Masters, Jeffrey Thomas Mullaney, Gerd Ruhter +4 more 2004-02-17
6528534 Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation Matthew Joseph Fisher, Joseph A. Jakubowski, John Joseph Masters, Jeffrey Thomas Mullaney, Kenneth J. Ruterbories +4 more 2003-03-04
6448269 Glycoprotein IIb/IIIa antagonists Matthew Joseph Fisher, Anne Marie Happ, Joseph A. Jakubowski, Michael Dean Kinnick, Allen D. Kline +9 more 2002-09-10 $109,326,000
6410562 Hypoglycemic imidazoline compounds Michael R. Jirousek, Gerd Ruhter, Theo Schotten, Kumiko Takeuchi, Wolfgang Stenzel 2002-06-25 $96,892,000
6291469 Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation Matthew Joseph Fisher, Joseph A. Jakubowski, John Joseph Masters, Jeffrey Thomas Mullaney, Kenneth J. Ruterbories +4 more 2001-09-18
6020362 Glycoprotein IIB IIIA antagonists Matthew Joseph Fisher, Anne Marie Happ, Joseph A. Jakubowski, Michael Dean Kinnick, Allen D. Kline +9 more 2000-02-01 $115,050,000
5731324 Glycoprotein IIb/IIIa antagonists Matthew Joseph Fisher, Anne Marie Happ, Joseph A. Jakubowski, Michael Dean Kinnick, Allen D. Kline +9 more 1998-03-24 $70,695,000
5672618 Protein kinase C inhibitors William F. Heath, Jr., John H. McDonald, III, Theo Schotten, Wolfgang Stenzel 1997-09-30 $60,335,000
5602136 Pyrimidine compounds and their use as pharmaceuticals Gerd R uhter, Theo Schotten, Wolfgang Stenzel 1997-02-11
5602137 Pyrimidine compounds and their use as pharmaceuticals Gerd R uhter, Theo Schotten, Wolfgang Stenzel 1997-02-11
5571813 Fused pyrimidine compounds and their use as pharmaceuticals Gerd R uhter, Theo Schotten, Wolfgang Stenzel 1996-11-05
5545636 Protein kinase C inhibitors William F. Heath, Jr., John H. McDonald, III, Gerd R uhter, Theo Schotten, Wolfgang Stenzel 1996-08-13 $37,061,000
4965352 Anthracycline derivatives having cytostatic activity Cenek Kolar, Peter Hermentin, Hans Kraemer 1990-10-23
4948880 Anthracycline derivatives having cytostatic activity Peter Hermentin, Hans Kraemer, Cenek Kolar, Dieter Hoffmann, Manfred Gerken +2 more 1990-08-14
4914191 Anthracycline derivatives having cytostatic activity Peter Hermentin, Cenek Kolar, Hans Kraemer, Dieter Hoffmann, Hans G. Berscheid +1 more 1990-04-03